|
|
|
Volumn 147, Issue 20, 2005, Pages 35-39
|
|
Tumor markers - How they should be applied;Tumormarker gehören nicht zum routine-check-up
|
|
Author keywords
Monitoring; PSA; Therapy control; Tumor markers
|
|
Indexed keywords
ALPHA FETOPROTEIN;
CA 125 ANTIGEN;
CA 15-3 ANTIGEN;
CA 19-9 ANTIGEN;
CA 72-4 ANTIGEN;
CALCITONIN;
CARCINOEMBRYONIC ANTIGEN;
CHORIONIC GONADOTROPIN;
CYTOKERATIN 19 FRAGMENT;
NEURON SPECIFIC ENOLASE;
PROGASTRIN RELEASING PEPTIDE;
PROSTATE SPECIFIC ANTIGEN;
PROTEIN S 100;
THYROGLOBULIN;
TUMOR MARKER;
CANCER ADJUVANT THERAPY;
CANCER DIAGNOSIS;
CANCER RADIOTHERAPY;
CANCER SCREENING;
CANCER STAGING;
COLON CARCINOMA;
DISEASE COURSE;
FOLLOW UP;
GERM CELL TUMOR;
HUMAN;
LIVER METASTASIS;
PATIENT MONITORING;
PREOPERATIVE EVALUATION;
SHORT SURVEY;
ADJUVANT CHEMOTHERAPY;
ARTICLE;
BLOOD;
MASS SCREENING;
MULTIMODALITY CANCER THERAPY;
NEOPLASM;
PREDICTION AND FORECASTING;
PROGNOSIS;
REFERENCE VALUE;
TUMOR RECURRENCE;
CHEMOTHERAPY, ADJUVANT;
COMBINED MODALITY THERAPY;
FOLLOW-UP STUDIES;
HUMANS;
MASS SCREENING;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASMS;
PREDICTIVE VALUE OF TESTS;
PROGNOSIS;
REFERENCE VALUES;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 20444379982
PISSN: 14383276
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (7)
|
|
References (0)
|
